Northern Trust Corp Alx Oncology Holdings Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Northern Trust Corp holds 319,742 shares of ALXO stock, worth $585,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,742

Previous 244,551 30.75%

Holding current value

$585,127

Previous $1.47 Million 60.58%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.81 - $8.13 $136,095 - $611,302	75,191 Added 30.75%	319,742 $581,000
Q2 2024 Aug 14, 2024	SELL	$5.84 - $17.56 $3,860 - $11,607	-661 Reduced 0.27%	244,551 $1.47 Million
Q1 2024 May 14, 2024	BUY	$10.95 - $16.79 $15,023 - $23,035	1,372 Added 0.56%	245,212 $2.73 Million
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $251,639 - $804,620	52,316 Added 27.32%	243,840 $3.63 Million
Q3 2023 Nov 13, 2023	SELL	$4.19 - $7.35 $4,935 - $8,658	-1,178 Reduced 0.61%	191,524 $919,000
Q2 2023 Aug 11, 2023	SELL	$4.37 - $9.56 $25,586 - $55,973	-5,855 Reduced 2.95%	192,702 $1.45 Million
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $19,770 - $51,219	-4,374 Reduced 2.16%	198,557 $897,000
Q4 2022 Feb 13, 2023	SELL	$9.51 - $12.95 $825,810 - $1.12 Million	-86,836 Reduced 29.97%	202,931 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $738,897 - $1.36 Million	89,781 Added 44.89%	289,767 $2.77 Million
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $154,859 - $511,642	26,292 Added 15.14%	199,986 $1.62 Million
Q1 2022 May 13, 2022	SELL	$13.65 - $22.06 $1,515 - $2,448	-111 Reduced 0.06%	173,694 $2.94 Million
Q4 2021 Feb 08, 2022	SELL	$21.49 - $74.4 $18,459 - $63,909	-859 Reduced 0.49%	173,805 $3.74 Million
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $190,296 - $293,217	3,624 Added 2.12%	174,664 $12.9 Million
Q2 2021 Aug 13, 2021	SELL	$52.2 - $75.23 $261,522 - $376,902	-5,010 Reduced 2.85%	171,040 $9.35 Million
Q1 2021 May 12, 2021	BUY	$62.84 - $87.68 $3.52 Million - $4.91 Million	56,003 Added 46.65%	176,050 $13 Million
Q4 2020 Feb 11, 2021	BUY	$34.11 - $112.26 $144,319 - $474,972	4,231 Added 3.65%	120,047 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $3.4 Million - $5.45 Million	115,816 New	115,816 $4.37 Million

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Alx Oncology Holdings Inc Transaction History